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THE ROLE OF SERPINA3 IN THE PATHOGENESIS OF KIDNEY DISEASE   
ELYSIA OTHELIA HEILIG  
ABSTRACT 
 Chronic kidney disease (CKD), defined as a decrease in renal function, is a global 
issue. The treatment of CKD and its comorbidities imparts a costly burden on the 
American healthcare system, therefore the need for therapeutics that prevent the 
progression of chronic kidney disease is urgent. Microarray studies have shown that the 
serine protease inhibitor clade A member 3 (SERPINA3) is transcriptionally upregulated 
in kidney injury. SERPINA3 is an extracellular protease inhibitor that maintains the 
homeostasis of extracellular matrix proteins. Our lab hypothesizes that SERPINA3 might 
not only be a transcriptional biomarker for kidney injury, but the SERPINA3 protein 
might act as a key upstream regulator in the advancement of renal inflammation and 
fibrosis. Our research characterizes the expression patterns of SERPINA3 in models of 
acute and chronic kidney injury through immunoblotting and immunohistochemistry. Our 
unilateral ureteral obstruction (UUO) model of chronic renal injury displays significant 
glomerular localization of SERPINA3. The adenine diet model of chronic kidney injury 
and the renal ischemic reperfusion injury (RIRI) model of acute kidney injury both 
display tubular upregulation of SERPINA3. The DOCA-salt hypertension model of 
chronic kidney injury was imposed on two strains of mice, C57BL/6 and 129/sv, both of 
which display tubular and glomerular upregulation of SERPINA3. However, the 
C57BL/6 strain, which is known for its resistance to glomerular sclerosis, displays higher 
renal localization of SERPINA3 when exposed to DOCA-salt hypertension, than does the 
  vii 
129/sv strain. In conclusion, our data suggests that SERPINA3 protein is upregulated in 
both acute and chronic kidney injury. The role of SERPINA3 in these models remains 
unknown, however, our lab theorizes that SERPINA3 protein may be renoprotective in 
certain instances of kidney injury. Functional assays must be performed to elucidate the 
role of SERPINA3 in these models of kidney injury. Characterizing the function of 
SERPINA3 in chronic and acute kidney injury might aid in the development of novel 
therapeutics to prevent the advancement of CKD.  
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INTRODUCTION 
 
Specific Aims 
 As the global rates of obesity, hypertension and diabetes continue to rise, a 
proportional increase in the prevalence of chronic kidney disease (CKD) is observed 
(Coresh, 2007). CKD is associated with a multitude of comorbidities, such as 
hyperlipidemia, cardiovascular disease and metabolic bone disease that result from loss 
of kidney function (Thomas, 2009). The treatment of CKD and its comorbidities imparts 
a costly burden on the American healthcare system, therefore the need for therapeutics 
that prevent or reverse kidney injury has increased (Jha 2013). Transcriptome data from 
several microarray studies (Table 1) has shown that serine protease inhibitor family A 
member 3 (SERPINA3) is consistently upregulated in various forms of kidney injury 
ranging from acute to chronic and immune based. 
Despite being a frequently upregulated gene in these data sets, very little is known 
about its protein expression in the normal kidney and its pathophysiological role in 
chronic kidney disease development and progression. These studies have led us to 
question whether the SERPINA3 protein itself is upregulated in acute and chronic kidney 
injury, and if so, what role does SERPINA3 play. The goal of this work is to characterize 
the translational expression patterns of SERPINA3 protein in clinically-relevant murine 
models of human kidney disease and to understand its role in kidney injury.  Elucidating 
the pathophysiological role of SERPINA3 in animal models of renal disease will expand 
the tools available for translational studies aiming to treat or reverse the progression of 
chronic kidney disease.   
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Acute kidney injury versus chronic kidney injury 
Kidney disease is organized into two main categories: acute kidney injury (AKI) 
and chronic kidney injury (CKI). AKI occurs rapidly over a short period of time and may 
be reversible. Common causes of AKI are ischemic events, shock, blood loss, sepsis, 
toxic exposure and kidney transplants (Figure 1). The histological hallmark of AKI is 
acute tubular necrosis and infiltration of inflammatory cells. The pathophysiology of AKI 
is associated with decreased glomerular filtration rate (GFR), high blood creatinine 
(CRE), and identification of protein casts in the urine (Hesketh, 2014). Renal ischemic 
reperfusion injury is acute because onset is sudden, and renal function often returns 
within a week after injury (Hesketh, 2014). However, in some cases of AKI, there is no 
renal function return and AKI develops into CKD through continued inflammation, 
fibrosis and loss of renal structure.  
In CKD, injury onset is slow and loss of renal function is permanent.  CKD is 
defined as the progressive deterioration of kidney function. Kidney function is measured 
via glomerular filtration rate. Common causes of CKD are diabetes, acute renal injury, 
autoimmune diseases, ureteral obstruction, and hypertension (Figure 1). The result of the 
progression of CKD is end-stage-renal disease (ESRD), during which patients retain 15% 
or less of normal kidney function (Thomas, 2009). Histological analysis of kidney 
biopsies from CKD patients reveals renal interstitial fibrosis, glomerulosclerosis, 
transformation of tubular epithelial cells into fibroblasts and myocytes, excessive 
deposition of collagen fibers, stiffening of the glomerulus, and infiltration of the kidney 
with immune cells (Diwan, 2018). Pathophysiologically, patients with CKD experience 
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albuminuria (protein in the urine) and the retainment of uremic solutes in their blood. As 
GFR decreases with loss of kidney function, the kidneys lose the ability to clear CRE out 
of the blood and CRE levels increase. Therefore, measurements of blood CRE blood 
levels are used as a direct measurement of GFR. Normal GFR for a healthy adult is 
indicated by greater than 90 milliliters of blood cleared per minute, with the absence of 
proteinuria. A doubled CRE blood value indicates a halved GFR or 50% reduction in 
normal renal function (Thomas, 2009). 
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Figure 1. Acute versus chronic kidney injury / Comparing how acute and chronic kidney injury 
differ in pathophysiology and histology. 
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Tubular versus glomerular kidney injury 
In addition to being categorized by duration of insult, kidney injury can be further 
subcategorized by specifying region of insult as either tubular or glomerular. The 
functional parts of the kidney are primarily divided into the glomeruli and the tubules. In 
the tubular region, cuboidal epithelial cells make up the nephron tubules that filter wastes 
out of the blood. The nephron is divided into proximal, distal, and convoluted tubules. 
Damage to tubular epithelium results in renal inability to appropriately filter wastes out 
of the blood and loss of renal ability to regulate blood osmolality. As result, patients have 
a buildup of uremic solutes and excessive loss of water and ions through excretion. 
Common causes of renal tubular epithelial damage are toxins like adenine or gentamicin, 
ureteral obstruction, and ischemic reperfusion (Figure 2). The glomerular region of the 
kidney pertains to glomeruli. Every glomerulus consists of a Bowman’s capsule 
epithelium that surrounds a ball-shaped bed of glomerular capillaries. These capillaries 
are made of endothelial cells which are surrounded by supportive podocytes. Mesangial 
cells reside in the interstitial spaces between the glomerular capillaries.  Glomerular 
injury manifests as glomerular sclerosis, a condition in which excessive ECM deposition 
prevents adequate flow of blood between glomerular capillaries and nephron tubules. 
Glomerular dysfunction results in the inability of blood plasma to enter the nephron 
tubular network, and therefore wastes cannot be filtered out of the blood. Common 
causes of glomerular dysfunction are toxins like adriamycin and streptozotocin, diabetic 
nephropathy, autoimmune disease (anti-GBM antibody complex deposits), hypertension 
and a reduction in renal mass (Figure 2) (Javaid, 2001).  
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Figure 2. Tubular vs glomerular injury / Common causes of renal 
tubular and glomerular injury. 
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Structure and Function of SERPINA3 
SERPINA3 is an extracellular protein composed of 423 amino acids. Structurally, 
it consists of eight alpha helices, three beta sheets and a reactive center loop (RCL) 
(Baker, 2007). The literature indicates that SERPINA3 molecular weight falls between 47 
- 60 kDa due to multiple sites of glycosylation (Hwang, 1999). SERPINA3 is a serine 
protease inhibitor that acts primarily outside of the cell. Protease attack of the SERPINA3 
RCL results in the formation of an irreversible, in active serpin-protease complex 
(Potempa, 1994). This protease has a significant homeostatic role, in that it regulates the 
activity of numerous proteases, and in this way, directs extracellular matrix (ECM) 
remodeling. ECM consists of the proteins outside of cells that are responsible for cell 
adhesion, cell structure and support, cell mobility, cell signaling, cell viability, and much 
more. Figure 3 lists the six proteases most commonly inhibited by SERPINA3. MMP2 
and MMP9 are gelatinases that cleave ECM proteins. A recent study has shown that 
when SERPINA3 transcription is inhibited in colorectal cancer (CRC) tissue, there is a 
significant decrease in MMP2 and MMP9 activity (Cao, 2018). This suggests that MMP2 
and MMP9 are downstream targets of SERPINA3 signaling, and by regulating these 
ECM proteases, SERPINA3 indirectly influences ECM remodeling.  
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SERPINA3 as an acute phase response protein 
SERPINA3 is a serine protease inhibitor whose synthesis is upregulated in 
response to activation of the acute phase signaling response pathway (Figure 4). Cell 
stressors such as infection, inflammation, tissue injury and cancerous cells directly 
activate macrophages, fibroblasts and endothelial cells to release signals that initiate the 
acute phase response pathway. IL-6 and OSM are pro-inflammatory cytokines that 
stimulate SERPINA3 synthesis via the acute phase response pathway (Kordula, 1998; 
Castell, 1989). These cytokines bind to receptors on the surface of the cell and direct 
STAT-3 and NF-kB to translocate to the nucleus as transcription factors (TFs). These TFs 
initiate synthesis of a set of acute phase proteins (APPs), SERPINA3 being among them 
(Baker, 2007) (Figure 4).  
 
 
Figure 3. Protease targets of SERPINA3 / Proteases most commonly inhibited 
by SERPINA3. 
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Figure 4. Acute phase response upregulation of SERPINA3 / Acute cellular stress stimulates the 
transcriptional and translational upregulation of SERPINA3 (Gruys et al, 2005 ; Baker et al, 2007). 
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SERPINA3 as a biomarker for kidney injury 
Microarray studies have exhibited that SERPINA3 mRNA is upregulated as part 
of the acute phase response to kidney injury (Table 1). Acute phase proteins are 
synthesized by hepatocytes and secreted into the blood. Clinicians use APP levels in the 
blood as diagnostic indicators of infection, injury and other types of stress. A microarray 
study performed in 2009 by Naesens analyzed kidney biopsies and found deceased-donor 
kidneys express significantly higher levels of acute phase proteins than live-donor 
kidneys, and SERPINA3 is one of the upregulated proteins. Additional microarray 
studies have disclosed that SERPINA3 is upregulated in both acute and chronic instances 
of renal injury, including but not limited to: injured renal transplant tissue, aging tissue 
and diabetic kidney tissue (Table 3). This confirms the SERPINA3 mRNA as a 
biomarker for kidney injury. In 2012, Famulski took biopsies from a large population of 
injured kidney transplants. The gene expression profile of these biopsies was analyzed 
via microarray and a set of 394 genes were found to be upregulated in injured kidney. 
These genes were named “the AKI signal”, or “injury-repair genes”, and SERPINA3 was 
among them (Famulski, 2012). Famulski then took this AKI gene set and used another 
large population of renal biopsies to assess whether upregulation of these genes had a 
positive correlation with renal rejection or renal failure. He found that while this gene set 
did not directly predict renal graft rejection, high AKI signal scores (high expression of 
these genes) in renal biopsies predicted renal failure (Famulski, 2013). While Famulski, 
Sigdal, Nasesens and others used microarray to exhibit SERPINA3 as a transcript 
consistently upregulated in response to renal injury, SERPINA3’s role in renal injury is 
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still unknown. Our lab hypothesizes that the consistent upregulation of SERPINA3 in 
kidney injury is indicative of SERPINA3 having a key role in the progression of kidney 
injury. Whether this role is renoprotective or exacerbates renal inflammation and fibrosis 
is unknown. 
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Author Journal 
Organ, 
Species 
Sample Pathology Summary 
Melk et al, 
2005 
Kidney 
International 
Kidney, 
human 
Renal cortex Aging kidney 
Old kidneys have 
increased EM turnover 
and nonspecific 
inflammatory response. 
Naesens et 
al, 2009 
JASN 
Kidney, 
human 
Biopsy prior to 
implantation 
Acute rejection, 
deceased donor  
Increased local 
complement correlates 
with increased "length of 
cold ischemia time and 
donor brain death".  
Weintraub et 
al, 2006 
Transplant 
International 
Kidney, 
human 
Biopsy 
Acute rejection, 
live donor 
Patients with highest risk 
of graft loss have 
increased expression of 
inflammatory genes and  
dominant B cell 
signature. 
Woroniecka 
et al, 2011 
Diabetes 
Kidney, 
human 
Biopsy: 
glomerular and 
tubular 
Diabetic kidney 
disease (DKD) 
SERPINA3 upregulated 
in diabetic kidney 
disease.  
Wilflingseder 
et al, 2014 
PLOS ONE 
Kidney, 
human 
2 biopsies: 
zero hour, and 
12 days post 
implantation. 
Kidney 
transplant with 
AKI 
Characterized a molecular 
signature of AKI. 
SERPINA3 upregulated 
expression in AKI 
biopsies.  
Zhang et al, 
2015 
PLOS ONE 
Kidney, 
mouse 
Whole kidney 
None; 
characterization 
of tissue-specific 
secretory factors 
Characterized SERPINA3 
expression in murine 
kidney. 
Sigdel et al, 
2017 
Frontiers in 
Medicine 
Kidney, 
mouse 
Blood sample, 
human 
Kidney 
transplant with 
AKI or CKI 
SERPINA3 upregulated 
in the serum of transplant 
sustaining kidney injury.  
Famulski et 
al, 2012 
JASN 
Kidney, 
human 
Kidney biopsy 
Kidney 
transplant with 
AKI 
Identified a set of 394 
"injury-repair genes" 
upregulated in biopsies of 
injured kidney 
transplants. This gene set 
labeled "the AKI signal".  
Famulski et 
al, 2013 
American 
Journal of 
Transplantation 
Kidney, 
human 
Kidney biopsy 
Kidney 
transplant with 
AKI 
Established high scores of 
"the AKI signal" 
predicted future renal 
graft failure.  
Table 1. Microarray studies identify SERPINA3 as biomarker for kidney injury / Studies 
used microarray technique to characterize the genetic profile of kidneys having experienced 
acute or chronic injury.  SERPINA3 mRNA transcript was found to be consistently upregulated 
in injured kidney tissue.  
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SERPINA3 role in disease 
The role of serine-protease-inhibitors (serpins) in kidney injury is not defined, 
however microarray studies have revealed SERPINA3 to be frequently upregulated in 
both acute and chronic kidney injury tissue (Table 1). Serpins are vital for maintaining 
homeostasis and as a result, any reduction in their activity will result in disease. Serpin 
activity reductions may occur by non-target proteinases, oxidative damage, and saturation 
with target proteinase, and genetic mutation that affects protein structure, localization or 
secretion (Potempa, 1994). Mutations in serpins disrupt homeostasis of the tissue and 
often result in disease. During sepsis, cleavage of the serpin RSL by exogenous 
proteinases results in serpin inactivation.  
When tissue displays an under-expression of SERPINA3, we often see excessive 
proteolysis and tissue damage resulting in diseases such as muscular dystrophy 
(weakening of sarcolemma in muscle fibers), poor wound healing in diabetics (Hsu 
2014), and aortic aneurysm (weakening of vessel wall integrity) (Tjondrokoesoemo, 
2016; Ang, 2011). Supplementation of SERPINA3 in these instances has promoted 
diabetic wound healing, sarcolemma strengthening in muscular dystrophy mice, vessel 
strengthening, and relief from neuropathic pain (Vicuna, 2017). Recent research has 
suggested that lower SERPINA3 mRNA levels in colorectal tissue may be a biomarker 
for colorectal cancer (CRC) progression (Dimberg, 2010). Despite this, overexpression of 
SERPINA3 is not always beneficial. High levels of SERPINA3 in gastric cancers is often 
predictive of poor prognosis (Allgayer, 1998). CRC studies have proven that silencing of 
SERPINA3 inhibits metastasis in colon cancer (Cao, 2018).  
 14 
METHODS 
 
Murine models of kidney injury 
Adenine model of tubular injury 
  Fourteen-day 0.25% adenine diet induces chronic renal failure in mice, injuring 
primarily the tubular cells of the kidney. This model is representative of patients with 
chronic renal failure due to toxin-exposure. C57BL/6 mice were administered food 
containing 0.25% adenine over a period of 14 days. SERPINA3 upregulation and 
localization was characterized at days 0, 4, and 14 of the adenine diet, using western 
blotting, immunofluorescence (IF) and H&E analysis.  Adenine is a chemical that causes 
acute kidney injury via tubular inflammation and calcification, over time leading to 
interstitial fibrosis and reduced GFR (Diwan, 2018). The pathophysiology and histology 
of this model is representative of chronic kidney disease seen in human patients (Jia, 
2013). 
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Figure 5. Surgical models of kidney injury / Surgical techniques used to create kidney injury 
models. The DOCA-salt model of glomerular HTN is created by Uninephrectomy at day 0, followed 
by administration of 1% NaCl and subcutaneous DOCA implantation for 42 days. Ureteral 
obstruction model is created by ligating left ureter for 1, 2, 3 and 4 weeks. Renal ischemic reperfusion 
injury is induced by ligating the left pedicle for 23 minutes and then allowing renal reperfusion.  
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DOCA-salt model of glomerular injury 
  DOCA-Salt uninephrectomy model induces glomerular hypertension in C57BL/6 
mice. This model recapitulates the key characteristics of human CKD, which are renal 
interstitial fibrosis, proteinuria and chronic inflammation (Jia, 2013). Mice are surgically 
subjected to uninephrectomy, and postoperatively a time-released DOCA pellet is 
subcutaneously implanted and mice are administered 1% NaCl drinking solution (Figure 
5). The high-salt diet promotes sodium retention, which causes volume retention. DOCA 
helps induce hypertension, promoting hyperfiltration and contributing to proteinuria 
(Mohammed-ali, 2004).  Prior to ischemic event, the right kidney is removed and used as 
a control (tissue labeled UniNx). The left kidney remains in the mouse, tissue labeled 
“DOCA”.  The subcutaneous DOCA pellet contains 150 mg deoxycorticosterone acetate. 
Animals are euthanized and left kidneys are harvested 42 days after uninephrectomy. 
Histological analysis of DOCA kidneys reveals deposition of protein casts in renal 
tubules, glomerular sclerosis, tubular cell necrosis, macrophage infiltration and interstitial 
fibrosis (Mohammed-ali, 2004).  
Unilateral ureteral obstruction model of CKI 
  The unilateral ureteral obstruction (UUO) murine model is used to replicate 
chronic kidney disease in humans caused by ureteral blockage. In this model, the left 
ureter is obstructed for variable periods of time in order to produce renal inflammation 
and interstitial scarring. At day 0, a laparotomy is performed on the mouse, during which 
the left ureter is ligated and the right ureter remains intact (Figure 6).  The right kidney is 
referred to as the non-obstructed “compensating” kidney, while the left kidney is referred 
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to as the “obstructed” kidney. Mice are sewn back up and ureteral obstruction was 
allowed to progress for 1, 2, 3 and 4 weeks (Chevalier, 2009). During this time, retention 
of urine in the kidney increases pressure in the kidney, reducing blood flow into the 
kidney and reducing GFR (Yang, 2010). At each time point, both the non-ligated kidney 
(compensating) and the obstructed kidney were collected for SERPINA3 analysis in 
western blot and immunohistochemistry. Expression of SERPINA3 protein in the kidney 
was assessed using western blotting technique. Localization of SERPINA3 was 
visualized in the kidney using immunofluorescence. Assessment of renal structure 
damage was visualized using H&E analysis. C57BL/6 murine strain was used for the 
UUO model.   
Renal ischemic reperfusion model of kidney injury 
  The pathophysiology of AKI has been elucidated with the help of renal ischemic 
reperfusion injury (RIRI) murine model. This murine model of acute kidney injury uses 
surgical technique to temporarily occlude blood flow to the kidney (Figure 6). Upon 
return of blood flow to the occluded kidney, reactive oxygen species (ROS) are 
generated, which lead to inflammation, cell death and acute kidney failure (Havasi, 
2011). According to literature, the pathophysiology of AKI is sudden onset of reduced 
GFR (Basile, 2012). According to literature, 6-12 weeks after renal ischemic reperfusion 
injury, kidney histology reveals tubular cell necrosis, casts of dead cells, loss of tubular 
structure, infiltration of inflammatory cells and interstitial fibrosis (Le Clef, 2016). Acute 
injury resulting from RIRI is usually reversible, and kidney function returns to normal 
within a week of occlusion (Hesketh, 2014).  The pathophysiology and histology of 
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kidneys of RIRI model mice accurately represent the pathophysiology and histology 
findings of acute kidney injury in humans.  Patients can experience renal ischemic events 
from lack of renal perfusion due to dehydration, traumatic blood loss, sepsis or toxin 
exposure (Le Clef, 2016). Additionally, RIRI is inevitable in any renal transplant 
(Hesketh, 2014). Unfortunately, AKI can make patients more prone to developing CKD. 
As result, there is a significant need for investigation into therapies that may prevent or 
mitigate both acute and chronic renal injury. 
In our RIRI model, a laparotomy was performed on anesthetized mice.  On day 0, 
the right kidney was removed and saved as control tissue. A micro serafin clip was used 
to occlude the left renal artery and left renal vein for 23 minutes, after which the left 
kidney was permitted to re-perfuse (Hesketh, 2014). This was a survival surgery, and 
mice were sacrificed at time points of 0, 24, 48 and 96 hours post occlusion. The left 
kidney was harvested at these time points as a model of acute renal injury due to renal 
ischemic reperfusion. Western blot, immunofluorescence and H&E analysis were used to 
characterize the upregulation and localization of SERPINA3 in the RIRI kidney.  
 
Western blotting technique 
  Western blot was used to discern whether or not SERPINA3 protein expression is 
upregulated or downregulated in injured murine kidney tissue. Kidney tissue from four 
murine kidney disease models was run on western blot and probed with anti-Serpina3n 
antibody.  10% SDS-PAGE gels were used to run tissue and cell-derived protein lysates. 
All sample lysates were run using 10% SDS-PAGE. Variable amounts of sample were 
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loaded per well depending on protein concentration.  Gels were run at 100 volts for 1.5 
hours or until foot of gel reached bottom of cassette. Protein-containing gels were then 
put in running buffer and protein was transferred from gel to nitrocellulose PVD 
membrane at 100 volts for 60min at 4◦C. Ponceau stain was used to visualize protein and 
cut blot at appropriate molecular weights. Blot was washed in 0.5% TBS-T and blocked 
in 5% milk-TBS-T for 1 hour. Blot was then incubated in primary antibody diluted in 5% 
BSA-TBS-T overnight at 4◦C. Blots were then washed in TBS-T and blocked for 1 hour 
at room temp in 5% milk in TBS-T. Finally, blots were incubated in secondary antibody 
for 1 hour at room temperature. Two methods were used to expose and visualize blot: 
camera with ECL substrate exposure, or film (HyBlot CL autoradiography film from 
Denville Scientific, Cat#E3018) with Immobilion substrate exposure. 
 
BCA assay 
The BCA assay is used to measure the concentration of protein in lysates prepared 
from animal tissue. Murine organ tissue was snap frozen in liquid nitrogen and stored at -
80◦C until use. Day of blot sample preparation, tissue was removed from -80◦C. Fresh 
gentle lysis buffer (GLB) and a homogenizer were used to grind of the tissue into large 
pieces, and then a sonicator was subsequently used to grind up the smaller tissues. After 
tissue lysis, tissue samples were spun at 14,000 RPM for 15 minutes at 4◦C. Supernatant 
containing protein was collected and pellet tossed. The supernatant was transferred to 
new 1.5 mL tubes. Next, Pierce BCA Protein Assay kit#23227 was taken out. Working 
reagent was prepared reagent A: reagent B, 50:1. In a 96 well plate, 200 µL of working 
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reagent was added per well. 10 µL of standard dilution or unknown sample were added 
per well, and plate was incubated 30 min at room temperature. Using the BioDrop, 
absorbance measurement was obtained at 562 nm. A standard curve was prepared from 
BSA protein. Absorbances at 562 nm were measured for BSA protein at 0, 0.06, 0.125, 
0.25, 0.5 and 1 mg/mL diluted in lysis buffer. These absorbances were plotted and a best-
fit standard curve was obtained. Unknown sample absorbances were obtained using the 
BioDrop: 2 µL of sample was added to the nanodrop and absorbance measurement was 
taken at 562 nm. The equation for the best-fit standard curve was used to determine 
unknown sample lysate protein concentrations by plugging their absorbance into the 
equation.  After determination of protein concentration µg/µL of sample lysates, the 
samples can be prepared to run on western. SDS-BME buffer was prepared. All lysates 
were normalized to the same concentration by addition of lysis buffer. Next, SDS-BME 
buffer was added to lysates in 1:4, buffer: lysate ratio. Lysates containing buffer were 
mixed and boiled at 95◦C for 5 minutes and then allowed to cool at room temperature 
before loading into gel.   
 
Bradford assay 
Bradford assay is used to measure concentration of protein present in lysates 
prepared from cell culture. RIPA-lysed cell lysates are removed from -80◦C. Lysate was 
thawed on ice and spun down at 14,000g for 15 minutes in 4◦C. Supernatant containing 
protein was collected and pellet tossed. The supernatant was transferred to new 1.5 mL 
tubes. Bradford Assay was performed to measure the concentration of protein in the cell 
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culture – derived protein samples. 5X Bradford reagent was diluted 1:5 in deionized 
water. 10 µL of sample protein suspension was added to 1 mL of 1:5 Bradford reagent. 
BioDrop machine (80300660) used 595 nm absorbance measurements to identify 
concentration of protein in each sample. Deionized water was used as a machine 
reference. Background was eliminated by taking absorbance measurement of 10 µL 
RIPA-PMSF in 1 mL of 1:5 Bradford reagent. Absorbance was measured in cuvettes at 
595 nm. A standard curve prepared from BSA was used to estimate the protein 
concentration of each sample from its absorbance value.  
 
Immunohistochemistry technique 
  Tissue from murine models of kidney injury was fixed in formalin and embedded 
in paraffin wax. It was then sectioned via microtome and mounted onto a microscope 
slide. The localization of certain proteins within the tissue was visualized using 
fluorescent stain. Tissue was baked at 95ºC for 1 hour, then hydrated in xylene and 
ethanol. Hydrated tissue slides were then microwaved in 95◦C sodium citrate buffer pH 
6.0 for 20 minutes. 
 
Immunofluorescence protocol 
Tissue was fixed in 10% formalin and embedded in paraffin wax for sectioning on 
a microtome. Embedded tissue was cooled on ice and then sectioned at 4 µM thickness 
using a microtome. Sections were floated in a 37◦C water bath and mounted onto a glass 
microscope slide. Mounted tissue was either baked or dried overnight and then hydrated 
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by sequential immersion in xylene followed by 100% ethanol, 95% ethanol, 70% ethanol, 
and finally deionized water. After tissue was re-hydrated, it was transferred to warm 
sodium-citrate butter pH 6.0 and heated at 95◦C for 20 minutes to perform antigen 
retrieval. Antigen retrieval reverses cross linkage that occurs in tissue when it is fixed in 
formalin, allowing antibody stains to penetrate the tissue more evenly. After antigen 
retrieval, a hydrophobic marker was used to draw a circular border around the tissue on 
each slide. To each slide was added a permeabilizing solution of 0.3% triton, 0.5% TBS-
T, which covered the tissue for 10 minutes at room temperature. Next, the tissue was 
immersed in a blocking solution of 5% bovine serum albumin (BSA) in 0.3% tritonX, 
0.5% TBS-Tween for 45 minutes at room temperature. This step helped prevent 
nonspecific binding of the primary antibody. After blocking, primary antibody was 
prepared 1:200 in 5% BSA, 0.3% triton, 0.5% TBS-Tween and added to the tissue. The 
primary antibody was incubated on the tissue overnight at 4◦C. The next morning, slides 
were washed in PBS and secondary antibody was prepared at 1:500 in 5% BSA, 0.3% 
triton, 0.5% TBS-Tween. Secondary antibody was incubated on the tissue for one hour at 
room temperature. The tissue was then washed again with PBS. A mounting medium 
containing DAPI (Vectashield from Vector Laboratories, Inc, #H-1200) was added to the 
tissue on each slide and topped with a glass coverslip. The sides of the slip were sealed 
with clear nail polish. Slides were imaged using Olympus BX60 fluorescent microscope. 
Slides were stored at 4◦C for one month. 
For IF analysis of renal tissue in all injury models, anti-Serpina3n antibody (R&D 
Systems AF4709-SP) was used as primary antibody at 1:200 dilution in 5% BSA. Alexa 
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Fluor 586 was used at 1:500 dilution in 5% BSA. Images were obtained using Olympus 
BX60 fluorescent microscope with settings for all images: Exposure / gain / offset, 
“enhanced color” on Image J : 127 /  256 / 3.00 (same for all images) .  
 
Hematoxylin-eosin staining 
Specimens were processed and stained and Boston Medical Center histopathology 
core labs.   
 
Mammalian cell culture technique  
  293T cells, BUMPT and HK2 cells were cultured in Dulbecco’s Modified Eagle’s 
Medium (DMEM) containing 1% Penicillin-Streptomycin (PenStrep) and 10% fetal 
bovine serum (FBS). Cells were passed 1:10 every 2 days and frozen down in DMEM 
(Corning Cellgro #10-017-CV) containing FBS and dimethyl-sulfoxide (DMSO).  
Aseptic cell culture technique was used. All cell work was performed in a sterile cell 
culture hood with the fan on. All reagents were sterilized by manufacturer, filtration or 
autoclave. All media and trypsin was warmed to 37◦C in water bath before use on cells. 
  1 mL of warm 0.25% Trypsin-EDTA (TE) was added per p100 culture dish of 
adherent cells. TE was incubated on adherent cells for 2 minutes at 37C. When cell 
sloughing was visualized under microscope, TE was neutralized by addition of 9 mL 
plain DMEM. 1mL of TE-media cell suspension was added to a new p100 containing 9 
mL warm full DMEM. A freeze-down solution was prepared: 16 mL DMEM, 6 mL FBS, 
2 mL DMSO. One p100 plate of 85% confluent cells were trypsinized and spun down at 
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2500 RPM for 5 minutes. Media was aspirated, and cell pellet was re-suspended in 3 mL 
of freeze-down medium. 1mL of freeze-down cell suspension was added per 1 cryovial. 
Cryovials were then transferred to -80 ◦C freezer for one day before cells were 
transferred to liquid nitrogen for long-term storage. 
 
Plasmid amplification with E.coli 
Transforming E.coli 
Competent E.coli was removed from storage at -80◦C and thawed in a 37◦C water 
bath.  E.coli were heat shocked to encourage uptake of mouse Serpina3n plasmid (Table 
2C). This plasmid is a pCMV6-Entry vector, meaning it has resistance to kanamycin 
when cultured in E.coli, but no antibiotic resistance for selection in mammalian cells.  
E.coli were transferred into 8mL of LB Broth containing final dilution of 25 µg/mL 
kanamycin and allowed to grow in a 37◦C shaker for 45 minutes. During this incubation, 
cells that have taken up the plasmid during the heat shock process will transcribe and 
translate the plasmid DNA into protein. By the end of 45 minutes, only antibiotic-
resistant E.coli containing your plasmid will be alive in the Luria-Bertani (LB) broth. 
 
Expansion of transformed E.coli 
Take 50 µL of this transformed E.coli and gently dab onto two separate agar 
plates containing kanamycin antibiotic.  Put agar plates containing E. coli into a 37◦C 
incubator overnight. In the morning, observe colony growth. Within the radius of a 
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Bunsen flame, pipette 7 mL of sterile 37◦C LB-broth into a 15 mL bacterial tube. Add 3.5 
µL of 50 mg/mL kanamycin to the LB broth to get a final dilution of 25 µg/mL 
kanamycin. Remove agar plates containing transformed-E. coli growth from incubator. 
Sterilize a p200 pipet tip using the flame. Under the sterile flame, use a pipet to transfer 
one E.coli colony into the 7 mL kanamycin-LB broth. Loosely cap bacterial tube and 
place in 37◦C shaker at 200 RPM for 6-8 hours. After 6-8 hours, cloudy growth should be 
observed in the bacterial tube. Transfer 750 µL of transformed E. coli into a 1.5 mL tube 
containing 750 µL of 40% glycerol and store in -80◦C as glycerol stock. The remaining 
6.25 mL of E. coli suspension can be either used for mini prep or maxi prep.   
 
Plasmid purification from E.coli 
Mini prep 
For Mini prep, QIAprep Spin Miniprep kit #27106 kit was used to isolate target 
plasmid DNA. The 6.25 mL of transformed E.coli was spun down and the pellet was 
manipulated using the mini prep protocol. 
 
Maxi prep 
For Maxi Prep, SpinSmart HS Maxi Plasmid Purification kit (Denville Scientific 
#1001245) was used. The 6.25 mL of transformed E.coli cell suspension was transferred 
into 250 mL of sterile, 37C LB-broth and put on shaker at 220 RPM overnight. The next 
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morning, cloudy growth was observed in the 250 mL of broth. The broth was spun down 
and the pellet was manipulated using the Maxi Prep protocol. 
 
Transient transfection technique 
  Lipofectamine 2000 reagent was used to encourage cells to take up vector 
containing the SERPINA3 gene. This vector was only transiently carried by these cells, 
and after a few divisions, the exogenous vector is lost from the cell cytosol. Transient 
transfection (Figure 6) was used to temporarily overexpress SERPINA3 in 293T cells, 
creating a positive control cell lysate for western blot that marked the 55 kDa molecular 
weight band. The day prior to transfection, cells were plated so that they would be 60% 
confluent on the day of transfection. The day of transfection, Lipofectamine and DNA 
vectors were prepared in serum-free DMEM. A pCMV6-Entry empty vector was used as 
a negative control. Serpina3n from Origene in a pCMV6-Entry vector was used. 6-well 
plates of 293T cells at 60% confluence were transfected with 1.0 µg of plasmid per well.  
Lipofectamine and plasmid solutions were combined and incubated 20 minutes prior to 
adding to cells. Regular media was aspirated off the cells and replaced with ~1mL per 
well of serum-free DMEM containing lipofectamine and plasmid. Cells incubated for 4 
hours at 37◦C, 5% CO2 in the lipofectamine-plasmid DMEM solution. After 4 hours, the 
solution was aspirated off the cells and replaced with warm DMEM containing 10% FBS, 
1% PenStrep. Cells grew for 24 hours and then lysed with RIPA containing PMSF and 
frozen at -80◦C for western blot. 
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Figure 6. Transient transfection procedure / Lipofectamine2000 was used to make 293T (human 
embryonic kidney cells) permeable to transient uptake of exogenous plasmid. Cells overexpress 
SERPINA3 encoded by the plasmid for 2-3 days after uptake. Western blot is used to confirm 
overexpression. 
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Creation of a vector for transduction 
  The original human SERPINA3 plasmid obtained from Origene Cat # RC200509 
was in a pCMV6-Entry vector (Table 2A). This meant that it was resistant to kanamycin, 
but unable to be selected for in mammalian cells. This type of vector is able to be 
transiently transfected into 293T cells using lipofectamine.  Transient transfection means 
the cells only temporarily overexpress the provided protein, but eventually the plasmid is 
lost from the cell. In transduction of cells with plasmid, the cells uptake the plasmid and 
permanently integrate the exogenous DNA into the host cell genome. This is performed 
with the help of retroviral proteins that reverse transcribe the viral RNA into DNA that is 
permanently integrated into the host genome. Additionally, the vector must contain an 
antibiotic resistance that will allow us to select for transduced mammalian cells. With the 
collaboration of Dr. Nader Rahimi at Boston University School of Medicine, the human 
SERPINA3 protein DNA was cut out of the pCMV6-Entry vector using HindIII 
restriction enzymes and ligated into a pLNCX2 vector containing resistance to G418 in 
mammalian cells, and resistance to ampicillin in E.coli (Singh, 2005). 
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Figure 7. Vectors to overexpress SERPINA3 / (A) A PCMV6—entry vector containing human 
SERPINA3 used to transiently transfect cells. (B) A PCMV6—entry vector containing mouse SERPINA3 
(SA3N) used to transiently transfect cells. (C) A pLNCX2 vector containing human SERPINA3 used to 
permanently transduce cells (Singh, 2005). 
 
Table 2. Vectors for SERPINA3 overexpression / A summary of the vectors used to overexpress 
SERPINA3 in cultured kidney cells. 
Gene  Vector Purpose Source 
Human SERPINA3 
(NM_001085) 
pCMV6-Entry Transient Transfection Origene  #RC200509  
Human SERPINA3 
(NM_001085) 
pLNCX2  Transduction  Nader Rahimi, Ph.D. 
mouse serpina3N 
(NM_009252) 
pCMV6-Entry Transient Transfection Origene #MR206624 
 
A 
B 
C 
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Creation of a stable cell line 
With the help of retroviral proteins G and GP, BUMPT and HK2 cells were 
transduced with modified G418-resistant vector containing the human SERPINA3 gene 
(Table 2B, Figure 7C) (Singh, 2005).  293T cells were used as packaging cells. The 293T 
cells were plated into six p60 cell culture dishes at 40% confluence and transfected via 
lipofectamine with protein G, protein GP, and either empty pLNCX2 vector resistant to 
G418 (MYC-tagged) or the modified human SERPINA3 vector resistant to G418 (MYC-
tagged) in plain DMEM. After a 4-hour incubation with lipofectamine, plasmid and viral 
proteins, the transfection media was aspirated off the cells and replaced with full DMEM 
(10% FBS, 1% PenStrep). The transfected 293T cells grew for 48 hours. During that 
time, BUMPT cells were plated at 20% confluence in six p100 cell culture dishes. After 
48 hours, viral media was collected off the 293T cells, debris pelleted, and polybrene 
added. 293T cell lysates were collected for western blot confirmation of transfection. 
Viral media containing polybrene was then transferred to the BUMPT cells and incubated 
24 hours. After 24 hours, viral media was aspirated off BUMPT and replaced with full 
DMEM. BUMPT grew 12 hours and then were treated with G418 at 150 µg/µL. G418 
treatment was refreshed daily. After three days, cell lysates were collected for western 
blot analysis. A western blot was run with three samples: 293T cells transfected with 
virus and plasmid, BUMPT transfected with empty vector, and BUMPT transfected with 
human SERPINA3 vector. Nitrocellulose membrane containing blot proteins was probed 
using anti-MYC antibody. For successful transduction of cells, we expect to see at the 55 
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kDa molecular weight level: no band in empty vector lane, and a solid band in the lanes 
containing cells transfected with SERPINA3 vector.  
 32 
 
  
 
Figure 8. Transduction procedure / The goal was to transduce BUMPT and HK2 cells with a vector 
encoding SERPINA3. The result would be a stable cell line that continuously overexpresses SERPINA3 
protein. 
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Cell stress and viability with overexpression of SERPINA3 
  The goal of this assay was to determine if kidney cells overexpressing human 
SERPINA3 protein were more resistant to injury. Cells were plated at 60% confluence 
and transiently transfected with human SERPINA3 vector. Cells were then allowed to 
grow overnight, and the next day, the cells overexpressing SERPINA3 were then exposed 
to oxidative stress in the form of 10 mM hydrogen peroxide (Arafa, 2015). Cells were 
treated with hydrogen peroxide for 1 hour and then cell viability was measured using 
alamar blue (Bio-Rad # BUF012A). Fluorescence was measured at excitation 550 to 570 
nm and emission 585 nm on SpectraMax M3 plate reader using SoftmaxPro software. 
Fluorescence values were then used to determine percent cell viability (see appendix for 
calculations). Live cells reduce alamar blue reagent, producing a pink solute in the media. 
Therefore, intensity of pink fluorescence is directly proportional to quantity of live cells.  
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Figure 9. Summary of investigative workflow / (A) Mice were utilized to create murine models of 
acute and chronic kidney injury. Kidney tissue was then harvested and analyzed using western 
blotting and immunofluorescent analysis. (B) Cell culture of murine (BUMPT) and human kidney 
cells (293T & HK2) was used to utilized. 293T cells were transfected to overexpress SERPINA3 
protein for positive control. 293T, BUMPT and HK2 were transfected to overexpress SERPINA3, 
and then SERPINA3 effect on cell viability was analyzed.   
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RESULTS 
 
Positive control for SERPINA3 western blot 
293T cells are transfected with MYC-tagged mouse Serpina3n (mouse orthologue 
to SERPINA3) plasmid purchased from Origene (Cat# MR206624, NM_009252). After 
transfection, 293T cells overexpress the SERPINA3 protein encoded by the plasmid for 
1-2 days. Because the transfected plasmid is not incorporated into the host cell genome, 
the exogenous plasmid is lost after about 1-2 days through cell division. Cells transiently 
overexpressing SERPINA3 protein are lysed 24 hours after transfection and run on a 10% 
SDS-PAGE gel. Separated gel proteins are then transferred over to a nitrocellulose-PVD 
membrane. Probing of the blot with 1:500 anti-MYC monoclonal antibody confirms 
successful transfection of the cells with the plasmid (Figure 6). Probing of this blot with 
anti-Serpina3n antibody reveals a 55 kDa band, the molecular weight of SERPINA3, 
indicating that transient overexpression of SERPINA3 is successful. This cell lysate is 
used as a positive control for all subsequent western blots. 
 
Endogenous SERPINA3 in C57BL/6 organs 
Western blot is used as a method to semi-quantify the expression of SERPINA3 
protein in murine tissue. First, organ tissue from a wildtype C57BL/6 mouse is probed for 
SERPINA3 to determine endogenous levels in these organs. Results (Figure 10) reveal 
low endogenous levels of SERPINA3 in kidney tissues, and high endogenous levels of 
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SERPINA3 in subcutaneous fat, lung and heart. No prior data exists on quantification of 
SERPINA3 in murine organs at the translational level.  
 
 
 
 
 
 
 
 
 
  
 
Figure 10. MYC-SERPINA3 overexpressed in 293T cells / The western blot displays two bands 
around 55 kDa, the molecular weight of the MYC-tagged Serpina3n protein (Figure 7B, Table 2C), 
reveal successful plasmid transfection and overexpression of SERPINA3 in these cells. 
 
Figure 11. SERPINA3 in normal murine organs / Endogenous levels of SERPINA3 in normal murine 
C57BL/6 organs. Lane 1: 293T cells overexpressing SERPINA3 protein were used as a positive control. 
The organs containing the highest levels of endogenous SERPINA3 protein appear to be subcutaneous 
fat, Thymus, Lung and Heart. 
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Low endogenous SERPINA3 expression in the kidney 
Before we begin analyzing SERPINA3 in diseased kidney tissue, we need to 
characterize endogenous SERPINA3 localization and expression levels in normal 
C57BL/6 murine kidney tissue. SERPINA3 baseline levels in normal kidney are semi-
quantified using western blot analysis (Figure 11). Results suggest low levels of 
endogenous SERPINA3 in C57BL/6 murine kidney. Next, immunofluorescence 
technique is used to localize endogenous SERPINA3 in C57BL/6 murine kidney. Anti-
Serpina3n antibody was used to probe SERPINA3 in control C57BL/6 murine kidney 
(Figure 12A). Minimal to zero SERPINA3 protein is visualized, supporting the western 
blot results in Figure 11 that suggest low levels of endogenous SERPINA3 in control 
C57BL/6 murine kidney. H&E stain is used to highlight the structural histology of the 
control C57BL/6 murine kidney (Figure 12B).  Knowing that SERPINA3 is not 
expressed at high levels in the normal murine kidney allowed us to interpret any changes 
in SERPINA3 expression as being the result of model-induced kidney injury.  
 
 
 
  
Figure 12. SERPINA3 is not detectable in control C57BL/6 kidney / (A) H&E stain displays control murine 
kidney histology. (B&C) Immunofluorescent probe for SERPINA3 reveals undetectable endogenous expression in 
the normal murine kidney under physiological conditions.  
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UUO kidney induces upregulation of SERPINA3 in glomeruli and tubules of 
both compensating and obstructed kidneys  
Western blot analysis was performed on C57BL/6 kidney having undergone 
unilateral ureteral obstruction for 1, 2, 3 and 4 weeks (Figure 13). Blot samples are 
prepared from tissue and 15 micrograms of protein are loaded per well. Serpina3n-
transfected 293T cell lysate and wildtype C57BL/6 subcutaneous fat are used as positive 
controls for SERPINA3. At the 55 kDa molecular weight level, the positive control lanes 
present with dark bands. Both the compensating kidney (non-obstructed) and 2-week 
UUO (obstructed kidney two weeks post ischemic event) lanes present with darker bands 
than the wildtype C57BL/6 lane, indicating upregulation of SERPINA3 in these kidney 
injury model. Resulting blot reveals low endogenous levels of SERPINA3 in wildtype 
C57BL/6 kidney as expected.  
 
 
 
  
 
Figure 13. UUO injury induces SERPINA3 upregulation in compensating and 
obstructed kidneys / Western blot analysis suggests that ureteral obstruction injury 
induces translational upregulation of SERPINA3 in both the obstructed and compensating 
kidneys of C57BL/6 mice.  
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In Figure 14A, H&E stain was used to visualize renal morphological changes 
caused by unilateral ureteral obstruction. After 1 week of UUO, obstructed kidney 
displays initial stages of glomerular sclerosis, with thinning of the Bowman’s capsule 
epithelium and detachment of glomerular capillaries from the capsule. The beginnings of 
immune infiltration are noticed in the tubulointerstitial spaces. Compensating kidney 1-
week post UUO surgery looks quite similar to wildtype C57BL/6 kidney; proximal tubule 
cells are pink and cuboidal with dark nuclei and glomeruli look healthy. After 2 weeks, 
obstructed kidney displays extensive interstitial fibrosis, immune filtration, glomerular 
sclerosis and tubular atrophy. 2-week compensating kidney displays very mild 
glomerular sclerosis and tubular atrophy. After 3 weeks, obstructed kidney displays 
transition of tubular epithelium into fibrotic network, and glomeruli are completely 
sclerosed. 3-week compensating kidney displays mild tubular atrophy, but overall healthy 
proximal tubule epithelium. After 4 weeks, obstructed kidney displays complete 
deterioration of proximal tubules and complete transition of proximal epithelium into 
fibrotic material. Glomeruli are all completely sclerosed and nonfunctional. 4-week 
compensating kidney displays a healthy kidney phenotype similar to that of wildtype 
C57BL/6 kidney, suggesting tubular regeneration occurs.  
Figure 14B depicts immunofluorescent probe detection of SERPINA3 in 
C57BL/6 kidney tissue from mice having undergone unilateral ureteral obstruction. 
Tissue was probed with anti-Serpina3n antibody 1:200 and 586 nm Alexa Fluor 
secondary 1:500. Slides were imaged using Olympus BX60 microscope. ImageJ software 
was used to convert images to RGB files and then superimpose the SERPINA3 and DAPI 
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fluorescent stains. The resulting fluorescent images reveal that 1-week post left ureteral 
ligation, the compensating kidney shows no change of SERPINA3 localization from 
control kidney baseline (Figure 12C), while the 1-week obstructed kidney reveals 
significant upregulation of SERPINA3 localized to the proximal tubule cells. 2-weeks 
post UUO, the compensating kidney begins to reveal a slight upregulation and 
localization of SERPINA3 in the proximal tubules. 2-week obstructed kidney displays 
even higher SERPINA3 localization to proximal tubules than 1-week obstructed kidney. 
SERPINA3 upregulation and localization in proximal tubules peaks in both compensating 
kidney and obstructed kidney 3 weeks post UUO. 4 weeks post UUO, SERPINA3 levels 
are decreased from 3 weeks and comparable to those seen in 1 or 2-week compensating 
and obstructed kidneys.  
In Figure 14B, SERPINA3 increased protein expression is visualized in both 
compensating and obstructed kidneys 1 through 4 weeks post UUO. Immunofluorescent 
data supports western blotting results, which indicate that SERPINA3 is upregulated in 
UUO murine kidney. This data suggests the SERPINA3 protein might take part in the 
development of kidney injury. It is possible that the compensating kidney may upregulate 
SERPINA3 in response to obstruction of the left kidney. As the obstructed kidney 
becomes hypertensive and dilated, its ability to filter the blood is reduced.  The remaining 
unobstructed kidney has to take over renal function of the obstructed kidney, and thus 
acquires the label “compensating kidney”. This doubled workload imposes stress on the 
compensating kidney, and SERPINA3 may be upregulated in response to this kidney 
stress. Similarly, obstructed kidneys display significant upregulation of SERPINA3 
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within the first 3 weeks post UUO. This indicates that SERPINA3 may play a protective 
role in acute kidney injury. Once the obstructed kidney becomes fibrosed as in CKD 
(week 4), SERPINA3 expression begins to fall. This might be due to the fact that 
SERPINA3 protein’s role in this instance was to fight renal inflammation and fibrosis, 
and now that the obstructed kidney is fully fibrosed, SERPINA3 no longer has a role. At 
4-weeks post UUO, the levels of SERPINA3 in compensating kidney also have 
decreased. This may be due to the fact that SERPINA3 has done its job and successfully 
allowed the compensating kidney to regenerate sufficiently to take on the renal load of 
the obstructed kidney.  
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Figure 14. Obstructive renal injury causes structural damage and induces upregulation of 
SERPINA3 protein in glomeruli and tubules of both compensating and obstructed kidneys  
 
Figure 14A:  H&E stain reveals structural damage resulting from unilateral ureteral obstruction. 
Compensating kidney 1-week post UUO: Appears similar to control kidney. 1-week obstructed 
kidney: Immune cell infiltration and initial stages of tubular epithelium necrosis. Tubular cell death 
is indicated by lack of nuclei and loss of brush border. Compensating kidney 2 weeks post UUO 
displays tubular atrophy. 2-week obstructed kidney: Fibrosed with no interstitial space visible 
between tubules. Immune cell infiltration is noted. Atrophied tubules leave large gaps in kidney tissue. 
Compensating kidney 3 weeks post UUO: Widespread tubular epithelial necrosis and tubular atrophy. 
3-week obstructed kidney: Transition of tubular epithelium into fibrotic material, loss of renal 
structure.   Compensating kidney 4 weeks post UUO: Regeneration of tubular epithelium. 4-week 
obstructed kidney: Fully fibrotic kidney tissue with complete transition of tubule epithelium into 
ECM. Sclerotic, non-functional glomeruli remain. 
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Figure 14B: IF reveals glomerular upregulation of SERPINA3 protein in 2-week obstructed kidney. 
Compensating kidney displays primarily tubular epithelial upregulation of SERPINA3. Compensating 
kidney 1 week post UUO surgery does not reveal any change in SERPINA3 translational expression as 
compared to control murine kidney (Figure 12C).  1-week obstructed kidney reveals localization of 
SERPINA3 in the tubules and glomeruli.  Compensating kidney 2 weeks post UUO displays very minimal 
localization of SERPINA3 in glomeruli in 2-week obstructed kidney, glomerular localization of SERPINA3 
is very apparent.  Compensating kidney 3 weeks post obstruction reveals significant localization of 
SERPINA3 in glomeruli, apical tubular epithelium, and interstitial spaces. 3-week obstructed kidney 
displays peak upregulation and localization of SERPINA3 in both glomeruli and tubules. Compensating 
kidney 4 weeks post obstruction reveal downregulation of SERPINA3 expression, as compared to week-
3.  4-week obstructed kidney reveals overall downregulation of SERPINA3 expression. 
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Adenine CKI induces tubular epithelial upregulation of SERPINA3 
Fourteen-day 0.25% adenine diet uses toxic insult to induce renal tubular injury. 
In Figure 15, western blot analysis is performed on C57BL/6 kidney having undergone 
0.25% adenine diet for 4 and 14 days. Blot reveals low endogenous levels of SERPINA3 
in wildtype C57BL/6 kidney as expected. Bands reveal a significant increase in 
SERPINA3 protein expression 4 days and 14 days after initiation of 0.25% adenine diet.   
 
  
 
Figure 15. Adenine-induced CKI upregulates SERPINA3 protein expression in the kidney / 15 µg 
protein per well. Kidney tissue was harvested after 4 and 14 days on the 0.25% adenine diet. Western 
blot was run with an n=3 mice per condition. On average, SERPINA3 protein expression in C57BL/6 
kidney appears to increase as result of adenine-induced chronic kidney injury. 
 45 
Upon analysis of H&E slides for adenine diet mice (Figure 16A&B), we observe 
inflammation, tubular atrophy, and adenine crystals in the tubules. These characteristics 
are  similar to those of a human kidney displaying CKD. Figure 16A depicts untreated, 
healthy C57BL/6 kidney. Trichrome stained control and adenine diet murine kidney 
(Figure 16C&D) dyed collagen deposition blue. Mice fed adenine diet revealed 
significant renal fibrosis similar to that seen in human CKD patients (Figure 16D).   
Figure 16E&F depict immunofluorescent localization of SERPINA3 in kidney 
tissue of C57BL/6 mice fed a 0.25% adenine diet for 14 consecutive days.  Tissue was 
probed with anti- SERPINA3 primary antibody 1:200, followed by a 586 nm fluorescent 
secondary antibody 1:500.  14-day adenine kidney revealed SERPINA3 localization in 
the in apical portion of proximal tubule cells and interstitial space between tubule cells 
(Figure 16F). Compared to control C57BL/6 murine kidney (Figure 16E), it is clear that 
SERPINA3 expression is upregulated after 14 days on the adenine diet. These results 
support the western blotting results in Figure 15 that suggest that SERPINA3 expression 
is upregulated as result of adenine-induced CKD.  
The adenine diet murine model replicates the pathophysiological and histological 
effects seen in human CKD (Figure 1 & Figure 2). If SERPINA3 is upregulated in 
murine chronic kidney injury, this suggests that SERPINA3 protein is also upregulated in 
the kidneys of human CKD patients. The question is whether SERPINA3 is upregulated 
in response to adenine insult because it is protecting against further injury, or because it is 
exacerbating renal inflammation and fibrosis. 
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Figure 16. Adenine diet inflicts renal structural damage and induces upregulation of SERPINA3 
protein in tubules and glomeruli / (A) Normal kidney histology (B) 14-day 0.25% adenine diet kidney 
histology. Significant immune cell infiltration (dark nodules). Atrophied tubules leave large gaps in 
renal tissue and increased interstitial space. (C) Minimal collagen in healthy kidney (D) Trichrome dyes 
collagen fibers blue, highlighting significant fibrosis in the adenine kidney, similar to that seen in human 
CKD patients. (E) No SERPINA3 protein (red) in the normal kidney (F) IF reveals significant 
SERPINA3 protein upregulation in glomeruli and tubules of adenine kidney. 
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Renal ischemic reperfusion injury induces SERPINA3 upregulation in renal 
tubular epithelium 
 Figure 17 displays western blot analysis of C57BL/6 kidney having undergone an 
ischemic event, followed by reperfusion. Tissue was harvested 24, 48 and 96 hours post 
ischemic event. Blot samples were prepared from tissue and 15 micrograms of protein 
were loaded per well. Resulting blot revealed low endogenous levels of SERPINA3 in 
wildtype C57BL/6 kidney as expected. Blot revealed a significant increase in SERPINA3 
protein expression 24 and 48 hours after ischemic event. ImageJ quantification of bands 
indicates that the upregulation of SERPINA3 in kidney is significant.  
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Figure 17. RIRI induces transient upregulation of SERPINA3/ (A) Western blot identifies 
SERPINA3 expression in murine kidney at 24, 48, and 96 hours post ischemic event. (B) Bands 
were quantified using ImageJ software. Quantitative results indicate that SERPINA3 protein 
expression peaks at 48 hours post injury. 
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Upon analysis of H&E slides for mice having undergone RIRI, we observed AKI 
similar to that of a human kidney displaying AKI.  In Figure 18A, control kidney depicts 
normal, healthy murine kidney prior to ischemic event. 24 hours post occlusion, we 
visualize tubular atrophy signified by pale, flattened tubular epithelium lacking nuclei. 48 
hours post occlusion, we visualize tubular atrophy and necrosis. Glomeruli remain 
unaffected. 96 hours post occlusion, we visualize atrophied tubules, tubular cell necrosis 
and increased interstitial space between tubules. The glomeruli display no visible 
structural damage as result of renal ischemic injury.  
Figure 18B depicts C57BL/6 murine kidney tissue probed with anti-Serpina3n 
primary antibody 1:200, followed by a fluorescent 586 nm secondary antibody 1:500.   In 
control kidney endogenous SERPINA3 expression is nonexistent. In kidney 24 hours post 
occlusion, we note localization of SERPINA3 in the apical portion of proximal tubule 
epithelium. 48 hours post occlusion, localization of SERPINA3 is noted in proximal 
tubule epithelium. 96 hours post occlusion, a reduction in localization of SERPINA3 is 
noted, however it is still localized in the apical portion of proximal tubule cells. 
Immunofluorescent detection of SERPINA3 in RIRI kidney tissue supports western 
blot results. In Figure 18B, SERPINA3 protein levels peak at 48 hours and decline 
between 48 and 96 hours. The rapid upregulation of SERPINA3 protein expression 
in response to AKI suggests that SERPINA3 might not only be a biomarker, but 
might also have a functional role in in response to AKI. Figure 18B reveals that 
SERPINA3 protein upregulation is primarily tubular in response to RIRI.  
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Figure 18. RIRI damages renal tubules and induces tubular upregulation of SERPINA3 rotein / 
Left kidney pedicle was occluded for a period of 23 minutes and then allowed to perfuse. Kidney tissue 
was harvested at 24, 48 and 96 hours post ischemic event. Right kidneys of all mice were removed 
prior to left pedicle occlusion and used as the “control” kidney. 
(18A): H&E stain reveals structure of murine kidney at various time points post ischemic event. 
Control kidney depicts normal kidney prior to ischemic event. Interstitial space is minimal between 
proximal tubules. Proximal tubule cells are cuboidal with a brush border, minimal lumen space. 24 
hours: significant tubular epithelial necrosis is signified by pale, flattened tubular epithelium lacking 
nuclei. 48 hours: tubular cell necrosis in addition to healthy tubular epithelium. 96 hours post occlusion, 
we visualize regeneration of tubular epithelium. No apparent damage to glomerular structure is visible. 
(18B): In control kidney, endogenous SERPINA3 levels appear to be minimal to zero. 24 hours: 
localization of SERPINA3 in the apical portion of proximal tubule epithelium. 48 hours: significant 
localization of SERPINA3 still noted in proximal tubule epithelium. SERPINA3 expression peaks at 
48 hours and declines thereafter. 96 hours: a reduction in SERPINA3 is noted. RIRI does not appear 
to induce glomerular upregulation of SERPINA3. 
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DOCA-Salt CKI directs preferential upregulation of SERPINA3 in C57BL/6 
strain, suggesting renoprotective role 
Murine renal tissue exposed to DOCA-salt treatment for 42 days experiences 
kidney injury with pathophysiology and histology similar to that of human patients with 
CKD. In our experiments, we compared DOCA-salt induced HTN in two murine strains: 
C57BL/6 and 129/sv. Previous research has suggested that the C57BL/6 murine strain is 
more resistant to developing glomerular sclerosis than the 129/sv strain (Hartner, 2003). 
This is significant because if we could elucidate the mechanism by which the C57BL/6 
mice resist glomerular sclerosis, that information could be used to develop therapeutics to 
prevent glomerular sclerosis in human CKD patients. Our H&E results suggest that 
C57BL/6 does in fact portray far less tubular and glomerular injury than the 129/sv strain 
(Figure 19A) when both are subjected to 42 days of DOCA-salt induced glomerular 
HTN. Additionally, C57BL/6 glomeruli and proximal tubules also display significantly 
higher upregulation and localization of SERPINA3 protein than do 129/sv HTN kidney 
specimens (Figure 19B). Western blotting results that contradict this are insignificant 
because the DOCA-C57BL/6 group had an n=1.This finding provides support for the 
theory that SERPINA3 may play a renoprotective role, preventing glomerular and tubular 
injury.  
Western blot analysis was performed on C57BL/6 kidney having undergone 
DOCA-Salt treatment for 42 days (Figure 19A). Tissue was harvested 42 days post 
implantation of DOCA pellet and initiation of high-salt water diet. Blot samples were 
prepared from tissue and 15 micrograms of protein were loaded per well. ImageJ 
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quantification of bands indicates that the upregulation of SERPINA3 in kidney is 
significant. “Ctrl” kidney indicates the kidney tissue removed on day zero of 
uninephrectomy. Control 129 and Control BL6 lanes reveal a low endogenous expression 
of SERPINA3 as expected.  The bar graph in Figure 19B displays the quantification of 
western blot bands. Quantification of DOCA 129 bands indicates that SERPINA3 protein 
expression is upregulated in response to glomerular HTN. DOCA C57BL/6 tissue did not 
display upregulation of SERPINA3 from baseline. This data does not support the 
immunofluorescent results (Figure 20), which suggest C57BL/6 mice had a greater 
upregulation of SERPIN3 than did 129/sv mice. However, the tissue was only available 
in n=1 so this data is not significant.   
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Figure 19. DOCA-salt HTN induces upregulation of SERPINA3 in kidney / “Ctrl” kidney 
indicates the kidney tissue removed on day zero of uninephrectomy. Ctrl 129 and Ctrl BL6 lanes 
reveal a low endogenous expression of SERPINA3.  Quantification of DOCA 129 bands indicates 
that SERPINA3 protein expression is upregulated in response to glomerular HTN. DOCA C57BL/6 
tissue did not display upregulation of SERPINA3 from baseline, however the tissue was only available 
in n=1 so this data is not significant. 
A 
B 
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Figure 20. DOCA-Salt-induced HTN injury causes renal damage, and induces preferential 
upregulation of SERPINA3 protein in C57BL/6 strain 
  
 H&E: Stain reveals significant tubular necrosis and glomerular damage in DOCA-Salt-treated 
hypertensive kidneys (UniNX) from both murine strains. However, 129/sv displays more significant renal 
damage and less significant SERPINA3 upregulation as compared to C57BL/6 hypertensive kidney. 
“C57BL/6 HTN” kidney reveals significant tubular atrophy signified by flattened tubular cells that have 
lost their cuboidal shape and significant lumen space. Tubular cell necrosis and liquefaction is noted. 
However, C57BL/6 HTN kidney still appears healthier and less fibrosed than 1219/sv HTN kidney. 
129/sv HTN kidney reveals significant fibrosis and widespread apoptosis of tubular cells. Also noted is 
liquefaction and increased luminal space due to luminal atrophy.  
 
IF: Tissue was probed with anti-Serpina3n antibody 1:200, followed by a fluorescent 586 nm secondary 
antibody 1:500. IF detection of SERPINA3 in Control C57BL/6 kidney shows minimal to zero 
endogenous SERPINA3 localization. C57BL/6 HTN kidney displays significant upregulation of 
SERPINA3 expression, localized in the proximal tubules, interstitial space, and glomerulus. 129/sv HTN 
kidney also revealed upregulation of SERPINA3, however, SERPINA3 expression upregulation in 
129/sv kidney tissue is not as intense and appears to be localized primarily in proximal tubules. 
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Transient transfection of 293T with human SERPINA3 
293T cells were transiently transfected with MYC-tagged human SERPINA3 
plasmid from Origene (RC200509) (Table 2). Empty vector with the same backbone was 
transfected into 293T for control lysate (Figure 7). Positive control lysate was derived 
from 293T cells transfected with Serpina3n plasmid. Probing the blot with anti-MYC 
revealed successful transfection of the 293T cells with the human SERPINA3 plasmid 
(Figure 24). However, the mouse Serpina3n antibody was not able to detect the 
overexpression of human SERPINA3 protein in these lysates (Figure 25). Although the 
SERPINA3 (human) and SA3N (murine) proteins are orthologues, their protein structure 
may differ enough that a human-SERPINA3 specific antibody is required to detect the 
human protein.  
Inconclusive results for SERPINA3 viability assay  
When the viability assay performed with BUMPT cells yielded results with no significant 
difference between all samples. Further optimization of this assay is required. 
Transduction was successful in 293T cells, but unclear whether it was successful in 
BUMPT or HK2 cells. Therefore, when the viability assay performed with BUMPT cells 
yielded results with no significant difference between all samples, it was hard to pinpoint 
whether the experimental fault was due to the failure of SERPINA3 transfection into 
BUMPT, or whether the viability assay needed optimization. Troubleshooting can be 
done by ordering an anti-human SERPINA3 antibody, as well as optimizing the viability 
assay. The viability assay can be optimized by determining optimal cell confluence, 
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optimal hydrogen peroxide dosage for LD50, and determining optimal hydrogen peroxide 
incubation period. 
 
 
 
 
 
 
 
Figure 21. Overexpression of human SERPINA3 in human embryonic kidney cells / This blot was 
probed with anti-MYC antibody. MYC-tagged mouse SA3N-transfected 293T cells were used as positive 
control for SERPINA3 55 kDa band. 293T cells were transfected with MYC-tagged human SERPINA3 
plasmid. Although the SA3N antibody was unable to detect the overexpressed SERPINA3 in this lysate 
(Figure 22), anti-MYC was able to successfully probe the MYC-tagged SERPINA3 and prove that 
transfection was successful.   
 
 
 
 
Figure 22. Detection of SERPINA3 in mouse and human adult kidney cells / Blot probed with anti-
Serpina3n antibody. Human SERPINA3 and murine orthologue SA3N proteins have a molecular weight of 
about 47 kDa, with a band visualized around 55 kDa according to literature (Vicuna 2017). Endogenous 
SERPINA3 was detected in HK2 (human adult kidney) and BUMPT (murine proximal tubule) cell lines. 
293T cells were transfected with MYC-tagged human SERPINA3, however the SA3N antibody was unable 
to detect the overexpressed human protein. Positive control lysate made from 293T cells transfected with 
SA3N plasmid.  
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DISCUSSION 
Chronic kidney disease afflicts 8-16% of the world population, and prevalence is 
increasing daily. CKD not only negatively impacts one’s quality of life, but it is also a 
costly disease. Renal failure increases patient susceptibility for cardiovascular disease, 
thrombotic events, encephalopathy, dialysis, renal transplant, anaemia, mineral 
deficiencies, and electrolyte imbalances (Jha, 2013). Diabetes mellitus and obesity are 
two of the top causes for development of CKD. Because these diseases are more 
commonly associated with individuals of lower SES, a significant portion of patients 
treated for CKD rely on the government to fund their treatment. Therefore, increasing 
prevalence of CKD directly correlates to increasing healthcare cost burden on the 
government. The severity of this issue requires that increased efforts be put into scientific 
research for developing therapeutics to prevent, mitigate or reverse kidney injury.  
Our lab hopes that by elucidating the biomolecular pathways of proteins 
responsible for generating the clinical phenotype of chronic kidney injury, we may be 
able to identify biomarkers for development of therapeutics to prevent renal fibrosis and 
inflammation. Microarray studies identify SERPINA3 as one of the genes consistently 
upregulated in injured kidney tissue (Table 1). Microarray analysis is a powerful tool that 
allows us to analyze genome-wide changes in transcriptional expression across normal 
and diseased tissues. Previous techniques such as qPCR only allowed analysis of the 
expression of a few genes at a time in isolation. Single-gene analysis data is limited in 
scope because disease pathologies are often the result of complex biomolecular 
interactions which are defined by change in expression of entire gene sets. Microarray 
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technique allows us to identify entire gene sets whose changes in expression define a 
clinical phenotype. Famulski, Weintraub, Sigdel, and other scientists (Table 1) used 
microarray technique to identify genes differentially expressed in various cases of kidney 
injury. These transcriptional profiles of kidney injury are useful because researchers can 
pair them with literature to identify the gene families and metabolic pathways that these 
target genes are a part of. Using known interactions between these genes, researchers can 
construct a theoretical biomolecular pathway depicting the mechanism by which gene 
expression generates the clinical phenotype of kidney injury. A limitation of microarray 
is that it provides transcriptional expression information on SERPINA3 but does not tell 
us whether or not these transcripts are translated into protein, or what their role is.. 
Additionally, microarray provides an overwhelming amount of transcriptional expression 
data, therefore researchers often selectively pursue investigation of genes that support 
their specific field or hypothesis.  
Microarray studies have established that SERPINA3 is upregulated in various 
types of both chronic and acute kidney injury specimens (Table 1). Our lab is taking this 
information a step further and using functional assays to determine the role of the 
SERPINA3 protein in development of kidney injury. Currently, published studies 
detailing the functional role of the SERPINA3 protein in kidney injury do not exist. 
However, research has been performed regarding the SERPINA3 protein’s role in various 
other tissues and diseases. SERPINA3 protein has been indicated to have a protective role 
in diseases such as aneurysm development, wound healing, muscular dystrophy and 
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neuropathic pain. However, studies have also shown that overexpression of SERPINA3 
in cancers regularly correlates with bad prognosis.  
Our studies characterizing the SERPINA3 protein in kidney injury establish that 
SERPINA3 is consistently upregulated in acute, chronic, glomerular, and tubular kidney 
injury. Our obstructive models of chronic kidney injury display prominent glomerular 
upregulation of SERPINA3. Our ischemic reperfusion models of acute injury display 
transient upregulation of SERPINA3 in tubular epithelium, followed by regeneration and 
a downregulation of SERPINA3. Our toxin-induced CKI models portray prolonged 
tubular upregulation of SERPINA3. Our DOCA-Salt CKI models indicate tubular and 
glomerular upregulation of SERPINA3. This upregulation is more prominent in the BL6 
strain, which literature has established is more resistant to glomerular injury. All of our 
results suggest that SERPINA3 protein might be responsible for preventing kidney injury, 
or might help the kidney regenerate after experiencing injury.  
Our investigation has provided novel information characterizing the upregulation 
and localization of SERPINA3 protein in response to kidney injury. The next aim is to 
define the functional role of SERPINA3 in kidney injury. To do so, we must perform 
functional assays that establish cause and effect, as well as elucidate the biomolecular 
pathways of SERPINA3 action. A cellular stress assay will be used to analyze 
SERPINA3’s role in renal tubular cell viability. Adult human kidney cells are cultured to 
overexpress SERPINA3 protein, injured by addition of hydrogen peroxide, and then cell 
viability measured. Theoretically, if SERPINA3 is renoprotective as our lab 
hypothesizes, tubular epithelial cells overexpressing SERPINA3 might display higher cell 
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viability after exposure to injurious reactive oxygen species, than do cells not 
overexpressing SERPINA3. Another way to measure SERPINA3’s renoprotective 
function would be to use transgenic mice. Specifically, mice lacking one or both alleles 
of the SERPINA3 gene would then be exposed to renal stress. Kidneys of SERPINA3 
knockout mice would be compared to wildtype murine kidneys. An in-vivo model would 
be a better method for studying SERPINA3 function because it would be more 
representative of the clinical phenotype of the patient with kidney injury. 
The role of SERPINA3 in the C57BL/6 murine strain’s resistance to renal injury 
could be further investigated by replicating the four kidney injury models in 129/sv mice. 
The SERPINA3 protein expression patterns and renal physiology results of 129/sv and 
C57BL/6 strains could be compared. If C57BL/6 mice continue to sustain less renal 
injury and portray higher levels of SERPINA3 expression relative to 129/sv mice 
exposed to the same renal insults, this would suggest that SERPINA3 has renoprotective 
properties which play a key role in C57BL/6 strain resistance to kidney injury.  
To prove that SERPINA3 plays a key role in preventing renal cell death, we 
would need to characterize the molecular pathways by which SERPINA3 acts. As a 
serine-protease-inhibitor, we would identify targets of SERPINA3 activity using protease 
activity assays. Studies have linked MMP2 and MMP9 expression changes to 
SERPINA3. A gelatinase assay could be used to determine whether changes in 
SERPINA3 translational expression directly affect MMP2 and MMP9 activity. Cell 
culture models are used as a cost-efficient method to assess the viability of renal tubular 
epithelium in response to SERPINA3 protein overexpression. A more ideal model for 
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assessing the role of SERPINA3 in the kidney would be to knockout SERPINA3 in 
C57BL6 mice and assess resulting kidney physiology and function. Animal models are 
more accurate than cell culture models in their representation of kidney injury molecular 
and clinical phenotype. Animal models are useful in that they provide a controlled 
environment in which to study a specific clinical pathology. However, animal models are 
far more costly to use than cell culture, and therefore research using these models is 
limited.  
Understanding the mechanisms by which kidney injury is mitigated or 
exacerbated is important, because by identifying the key actors in these pathways, we 
identify target proteins for therapeutics that aim to prevent the progression of renal injury. 
Chronic kidney disease is an escalating global public health crisis that needs to be dealt 
with. Our lab hopes that by defining the role of the SERPINA3 protein in generating the 
kidney injury phenotype, the medical community may be better able to create targeted 
therapeutics for treating human kidney injury. 
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APPENDIX 
 
Year Author Journal Title Serpina3 Relevance 
2003 Hartner 
Nephrology 
Dialysis 
Transplantation 
Strain differences in the 
development of hypertension and 
glomerular 
lesions induced by 
deoxycorticosterone acetate salt in 
mice 
C57BL/6 strain is more 
resistant to DOCA-salt 
induced HTN, glomerular 
sclerosis and albuminuria. 
2006 Devarajan JASN 
Update on Mechanisms of Ischemic 
Acute Kidney Injury 
AKI mechanisms 
2009 Chevalier 
Kidney 
International 
Ureteral obstruction as a model of 
renal interstitial fibrosis and 
obstructive nephropathy 
Describes the UUO model 
2010 Yang 
Drug Discoveries 
Today Disease 
Models 
Models of chronic kidney disease 
UUO: within 24 hr reduced 
renal blood flow and GFR 
2010 Abishek Lyer 
Current 
Cardiology 
Review 
The DOCA-Salt Hypertensive Rat as 
a Model of Cardiovascular 
Oxidative and Inflammatory Stress 
Explains the DOCA-Salt 
model 
2011 Borkan 
Kidney 
International 
Apoptosis and acute kidney injury AKI and renal ischemia 
2013 Jia BMC Nephrology 
A novel model of adenine-induced 
tubulointerstitial nephropathy in 
mice 
Describes adenine diet 
murine model 
2014 Hesketh JOVE 
Renal Ischaemia Reperfusion Injury: 
A Mouse Model of Injury and 
Regeneration 
RIRI model methodology 
2014 Hesketh JOVE 
A murine model of irreversible and 
reversible unilateral ureteric 
obstruction 
UUO model methodology 
2014 Mohammed-ali 
Biomed Research 
International 
Development of a Model of Chronic 
Kidney Disease in the C57BL/6 
Mouse with Properties of 
Progressive Human CKD 
DOCA-salt model of CKD 
2016 Le Clef PLoS ONE 
Unilateral Renal Ischemia-
Reperfusion as a 
Robust Model for Acute to Chronic 
Kidney 
Injury in Mice 
RIRI as acute kidney injury 
model 
2018 Diwan Nephrology 
Adenine-induced chronic kidney 
disease in rats. 
Adenine model to induce 
CKD 
2018 Rahman PLoS ONE 
A novel approach to adenine-
induced chronic kidney disease 
associated anemia in rodents 
Adenine 
 
  
Table 3. References for models of kidney injury / Summary providing overview of sources used for 
research on models of acute and chronic kidney injury.  
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LIST OF JOURNAL ABBREVIATIONS 
 
JAMA JAMA: The Journal of the American Medical Association 
JASN Journal of the American Society of Nephrology 
JOVE Journal of Visualized Experiments 
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